The biopharmaceutical sector is one of Spanish strategic sectors due to its high added value for the Spanish business ecosystem, being one of the top ten sectors in the country in terms of stock in millions of euros of foreign direct investment. In addition, more than 60% of the pharmaceutical companies established in Spain are foreign-owned and have research, development and production centres of recognised prestige.

By joining this webinar, you will be able to learn about the strengths of Spain as a business location and investment destination in the biopharmaceutical sector, highlighting our country's leadership as one of the main innovation hubs for new developments in healthcare.

With an extensive network of 800 hospitals, both public and private, backed by leading-edge research centers, the Spanish healthcare system is ideal for translational medicine, the development of new drugs and advanced therapies. In addition, Spain is 12^th world scientific power and 3^rd by scientific production in the EU as well as a world leader in clinical testing.

PROGRAMME

10:55-11:00         Connection webex

11:00-11:05         Welcome and introduction

                            Spanish Economic and Trade Office in Stockholm

                            Counsellor, José Antonio Bretones

11:05-11:10         Spain as a global platform for business and investment

                            ICEX-Invest in Spain

                            FDI Project Director, Vanesa Álvarez

11:10-11:15         Why Spain for Life Sciences

                            ICEX-Invest in Spain

                            Life Sciences Project Manager, Bárbara López

11:15-11:30         Spain as an innovation hub for new developments

                            in the biopharma sector

                            Farmaindustria

                            Director of Clinical and Traslational Research, Amelia Martín

11:30-11:45         Successful business case: Astra Zeneca                             

                            Director of Corporate Affairs and Market Access, Marta Moreno

11:45-12:00         Successful business case: Verigraft

                         Chief Technology Officer, Raimund Strehl PhD

12:00-12:15         Q&A

REGISTRATION

For further information about the webinar and about the Spanish biopharmaceutical sector, please, contact us at barbara.lopez@icex.es

  Spain for Life Sciences.pdf